Cancer treatment

Open Access
Oral Fenbendazole for Cancer Therapy in Humans and Animals
JOLIE NGUYEN, THAI Q. NGUYEN, BO HAN and BA X. HOANG

Anticancer Research September 2024, 44 (9) 3725-3735; DOI: https://doi.org/10.21873/anticanres.17197
Open Access
Distress Scores During a Course of Radiotherapy: A Pilot Study
CANSU DELIKANLI, STEFAN JANSSEN, DIRK KEIL, SØREN TVILSTED, STEVEN E. SCHILD and DIRK RADES

Anticancer Research November 2022, 42 (11) 5561-5566; DOI: https://doi.org/10.21873/anticanres.16062
You have access
T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES

Anticancer Research March 2021, 41 (3) 1123-1141; DOI: https://doi.org/10.21873/anticanres.14870
You have access
T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES

Anticancer Research March 2021, 41 (3) 1143-1156; DOI: https://doi.org/10.21873/anticanres.14871
You have access
Anatomical Predictors of Dosimetric Advantages for Deep-inspiration-breath-hold 3D-conformal Radiotherapy Among Women With Left Breast Cancer
GIANLUCA FERINI, LAURA MOLINO, ANTONELLA TRIPOLI, VITO VALENTI, SALVATORE IVAN ILLARI, VALENTINA ANNA MARCHESE, IRENE RITA CRAVAGNO and GIUSEPPINA RITA BORZI

Anticancer Research March 2021, 41 (3) 1529-1538; DOI: https://doi.org/10.21873/anticanres.14912
You have access
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS

Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
You have access
Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer
SATOSHI OWADA, HITOSHI ENDO, CHISA OKADA, KAZUHIRO YOSHIDA, YUKARI SHIDA and MASAYUKI TATEMICHI

Anticancer Research September 2020, 40 (9) 5071-5079; DOI: https://doi.org/10.21873/anticanres.14510
You have access
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells
HIROTSUGU SAKAKI, MASASHI OKADA, KENTA KURAMOTO, HIROYUKI TAKEDA, HIKARU WATARAI, SHUHEI SUZUKI, SHIZUKA SEINO, MANABU SEINO, TSUYOSHI OHTA, SATORU NAGASE, HIROHISA KURACHI and CHIFUMI KITANAKA

Anticancer Research December 2015, 35 (12) 6607-6614;
You have access
Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters
VALENTINOS KOUNNIS, GEORGIOS CHONDROGIANNIS, MICHALIS D. MANTZARIS, ANDREAS G. TZAKOS, DEMOSTHENES FOKAS, NIKOLAOS A. PAPANIKOLAOU, VASILIKI GALANI, IOANNIS SAINIS and EVANGELOS BRIASOULIS

Anticancer Research November 2015, 35 (11) 5857-5865;
You have access
Predictive and Prognostic Value of the TauProtein in Breast Cancer
CLAIRE BONNEAU, ZACHARY A. GURARD-LEVIN, FABRICE ANDRE, LAJOS PUSZTAI and ROMAN ROUZIER

Anticancer Research October 2015, 35 (10) 5179-5184;

Main menu

User menu

Search

Cancer treatment

Pages